Intracerebroventricular Aβ-Induced Neuroinflammation Alters Peripheral Immune Responses in Rats
- 31 October 2018
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 66 (4) , 572-586
Abstract
An important marker in Alzheimer disease (AD) is the abnormal production and accumulation of β-amyloid peptide (Aß) in brain. It produces oxidative damage in neurons and inflammation due to its neurotoxic properties. The present study was designed to investigate neuroinflammation (hippocampal levels of ROS, nitrite, TNF-α, and IL-1β), neurodegeneration (plaques and chromatolysis in hippocampus), and memory impairments (working memory and reference memory) and the effect of this neuroinflammation on some peripheral immunological parameters such as phagocytic activity of blood WBC and splenic polymorphonuclear (PMN) cells, leucocyte adhesion inhibition index (LAI), and cytotoxicity of splenic mononuclear cells (MNC) after the intracebroventricular injection of aggregated Aβ(1–42)in a 4week study. The results showed that the hippocampal and serum levels of ROS, nitrite, TNF-α, and IL-1β were significantly higher in the AD animals along with increased chromatolysis and impairments of memory. There was also a significant increase in the phagocytic activity of splenic PMN and cytotoxicity of splenic MNC and a decrease in the phagocytic activity of blood WBC and LAI of splenic MNC in the Aβ(1–42)-injected AD rats compared to that of control and sham-operated rats. The results indicate that the increased levels of inflammatory markers in the hippocampus may provide signals to the periphery and can alter the systemic immune responses.Keywords
Funding Information
- National Tea Research Foundation (NTRF:166/2014)
This publication has 77 references indexed in Scilit:
- Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1–42) rat model of Alzheimer's diseasePhysiology & Behavior, 2013
- Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in RatsPLOS ONE, 2013
- The Role of Cytokines and Inflammatory Cells in Perinatal Brain InjuryNeurology Research International, 2012
- Intracerebroventricular Administration of Amyloid β-protein Oligomers Selectively Increases Dorsal Hippocampal Dialysate Glutamate Levels in the Awake RatSensors, 2008
- Amyloid-β (25–35) increases activity of neuronal NO-synthase in rat brainNeurochemistry International, 2008
- Decreased nicotinic receptors and cognitive deficit in rats intracerebroventricularly injected with beta‐amyloid peptide(1‐42) and fed a high‐cholesterol dietJournal of Neuroscience Research, 2007
- Blood–brain barrier impairment in Alzheimer diseaseNeurology, 2007
- A Century of Alzheimer's DiseaseScience, 2006
- Alzheimer?s associated inflammation, potential drug targets and future therapiesJournal of Neural Transmission, 2004
- Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemiaAnnals of Hematology, 1995